Loading...
XNAS
TRUG
Market cap5mUSD
Jul 09, Last price  
1.35USD
1D
0.75%
1Q
-64.47%
IPO
-98.63%
Name

Deep Medicine Acquisition Corp

Chart & Performance

D1W1MN
XNAS:TRUG chart
P/E
P/S
0.31
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
19m
-13.63%
0021,858,86421,858,86418,878,997
Net income
-15m
L+73.13%
-358,178-400,232-8,795,419-8,795,419-15,227,893
CFO
-2m
L-57.49%
-697,868-1,036,436-3,995,606-1,698,381

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.
URL
IPO date
Oct 27, 2021
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2026‑032025‑122025‑032024‑122023‑032022‑032021‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT